ZNF792 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.642800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.038800E-01
Normal-vs-Stage2
5.162200E-01
Normal-vs-Stage3
1.848590E-01
Normal-vs-Stage4
8.494200E-01
Stage1-vs-Stage2
3.905200E-01
Stage1-vs-Stage3
1.279170E-01
Stage1-vs-Stage4
6.627200E-01
Stage2-vs-Stage3
4.280000E-01
Stage2-vs-Stage4
5.627400E-01
Stage3-vs-Stage4
3.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.136000E-01
Normal-vs-AfricanAmerican
9.978200E-01
Normal-vs-Asian
7.576800E-01
Caucasian-vs-AfricanAmerican
2.539800E-01
Caucasian-vs-Asian
3.394600E-01
AfricanAmerican-vs-Asian
7.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.049400E-01
Normal-vs-Female
4.307800E-01
Male-vs-Female
7.894800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.548200E-01
Normal-vs-Age(41-60Yrs)
6.582600E-01
Normal-vs-Age(61-80Yrs)
4.200800E-01
Normal-vs-Age(81-100Yrs)
9.768100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.968000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.536800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.152650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.604400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.240030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.365200E-01
Normal-vs-Daily Drinker
2.630800E-01
Normal-vs-Weekly Drinker
2.232000E-01
Normal-vs-Occasional Drinker
8.506000E-01
Normal-vs-Social Drinker
7.492000E-01
Non Drinker-vs-Daily Drinker
5.274200E-01
Non Drinker-vs-Weekly Drinker
7.024000E-01
Non Drinker-vs-Occasional Drinker
1.959820E-01
Non Drinker-vs-Social Drinker
2.933000E-01
Daily Drinker-vs-Weekly Drinker
8.485400E-01
Daily Drinker-vs-Occasional Drinker
1.059350E-01
Daily Drinker-vs-Social Drinker
1.592790E-01
Weekly Drinker-vs-Occasional Drinker
1.729020E-01
Weekly Drinker-vs-Social Drinker
2.247600E-01
Occasional Drinker-vs-Social Drinker
8.501800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.600500E-02
Normal-vs-Grade 2
9.759100E-03
Normal-vs-Grade 3
9.215900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.198200E-02
Grade 1-vs-Grade 3
1.147010E-01
Grade 1-vs-Grade 4
2.600500E-02
Grade 2-vs-Grade 3
8.903200E-01
Grade 2-vs-Grade 4
9.759100E-03
Grade 3-vs-Grade 4
9.215900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.279200E-01
Normal-vs-NonDiabetic
4.632000E-01
Diabetic-vs-NonDiabetic
7.087200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.857400E-01
Normal-vs-NoPancreatitis
4.658400E-01
Pancreatitis-vs-NoPancreatitis
6.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.270200E-01
Normal-vs-N1
4.661400E-01
N0-vs-N1
5.975400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.133800E-01
Normal-vs-TP53-NonMutant
7.357400E-01
TP53-Mutant-vs-TP53-NonMutant
4.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
